RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
46.77
+0.73 (1.59%)
At close: Jul 19, 2024, 4:00 PM
46.82
+0.05 (0.11%)
Pre-market: Jul 22, 2024, 7:10 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $1.82 billion as of July 22, 2024. Its market cap has increased by 90.00% in one year.
Market Cap
1.82B
Enterprise Value
1.70B
1-Year Change
90.00%
Ranking
Category
Stock Price
$46.77
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.82B, an increase of 329.66%. That is a compound annual growth rate of 63.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.74B | 20.32% |
| Dec 29, 2023 | 1.45B | 311.70% |
| Dec 30, 2022 | 351.20M | 14.14% |
| Dec 31, 2021 | 307.70M | -27.49% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 1.86B |
| Verona Pharma | 1.86B |
| NeoGenomics | 1.85B |
| Akero Therapeutics | 1.85B |
| Zai Lab | 1.85B |
| Harmony Biosciences Holdings | 1.82B |
| Neumora Therapeutics | 1.80B |
| Ligand Pharmaceuticals | 1.79B |